EyePoint, Inc. (EYPT)
12.33
+0.56
(+4.76%)
USD |
NASDAQ |
Jun 10, 16:00
12.09
-0.24
(-1.95%)
After-Hours: 20:00
EyePoint EPS Diluted (TTM) : -3.502 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -3.502 |
| December 31, 2025 | -3.163 |
| September 30, 2025 | -2.990 |
| June 30, 2025 | -2.678 |
| March 31, 2025 | -2.408 |
| December 31, 2024 | -2.313 |
| September 30, 2024 | -2.006 |
| June 30, 2024 | -1.796 |
| March 31, 2024 | -1.827 |
| December 31, 2023 | -1.838 |
| September 30, 2023 | -2.667 |
| June 30, 2023 | -2.831 |
| March 31, 2023 | -2.741 |
| December 31, 2022 | -2.740 |
| September 30, 2022 | -2.171 |
| June 30, 2022 | -2.258 |
| March 31, 2022 | -2.086 |
| December 31, 2021 | -2.019 |
| September 30, 2021 | -2.492 |
| June 30, 2021 | -2.209 |
| March 31, 2021 | -2.898 |
| December 31, 2020 | -3.542 |
| September 30, 2020 | -3.451 |
| June 30, 2020 | -4.617 |
| March 31, 2020 | -4.662 |
| Date | Value |
|---|---|
| December 31, 2019 | -5.537 |
| September 30, 2019 | -5.761 |
| June 30, 2019 | -8.698 |
| March 31, 2019 | -13.82 |
| December 31, 2018 | -13.30 |
| September 30, 2018 | -13.70 |
| June 30, 2018 | -10.80 |
| March 31, 2018 | -4.620 |
| June 30, 2017 | -5.220 |
| March 31, 2017 | -5.520 |
| December 31, 2016 | -5.520 |
| September 30, 2016 | -7.30 |
| June 30, 2016 | -6.90 |
| March 31, 2016 | -6.70 |
| December 31, 2015 | -6.90 |
| September 30, 2015 | -6.50 |
| June 30, 2015 | 1.90 |
| March 31, 2015 | 2.20 |
| December 31, 2014 | 3.10 |
| September 30, 2014 | 3.20 |
| June 30, 2014 | -4.90 |
| March 31, 2014 | -5.20 |
| December 31, 2013 | -5.60 |
| September 30, 2013 | -5.40 |
| June 30, 2013 | -5.10 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Ocular Therapeutix, Inc. | -1.456 |
| Rapport Therapeutics, Inc. | -2.603 |
| Merck & Co., Inc. | 3.553 |
| Bristol Myers Squibb Co. | 3.563 |
| Praxis Precision Medicines, Inc. | -13.38 |